TDC
IMPV

Thompson Davis & Co’s Imperva, Inc. IMPV Stock Holding History

Thompson Davis & Co’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-125
Closed -$8K – 1298
2015
Q2 		$8K Buy
+125
New +$6.9K 0.01% 793
2015
Q1 		– Sell
-250
Closed -$12K – 1308
2014
Q4 		$12K Buy
+250
New +$10K 0.01% 694

Other funds holding IMPV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Thompson Davis & Co's IMPV Position: Q3 2015 in Review

Thompson Davis & Co sold out of Imperva, Inc. (IMPV) in Q3 2015, closing a stake of 125 shares — an estimated $8K sold.

Thompson Davis & Co first reported a position in IMPV in Q4 2014 and held it in 2 quarters. The position peaked at $12K in Q4 2014. 180 funds tracked by Wall St. Rank hold IMPV as of Q3 2015.

  • Thompson Davis & Co reported no remaining Imperva, Inc. position as of Q3 2015 after selling out during the quarter.
  • Thompson Davis & Co sold 125 Imperva, Inc. shares in Q3 2015, an estimated $8K.
  • Thompson Davis & Co first reported a position in Imperva, Inc. in Q4 2014 and held it in 2 quarters.
  • Thompson Davis & Co's Imperva, Inc. position peaked at $12K in Q4 2014.
  • 180 funds tracked by Wall St. Rank held Imperva, Inc. as of Q3 2015.

Based on Thompson Davis & Co's 13F filing for Q3 2015, filed 30 Oct 2015.